People with rare disorders have a worse healthcare experience than those affected by chronic diseases, according to the results of…
Articles by Marta Figueiredo
The first wave of COVID-19Â in Europe severely disrupted access to care and raised stress and anxiety in people with…
A short interruption in in-person medical visits due to the COVID-19 pandemic significantly decreased treatment adherence but had little…
Treatments blocking interleukin (IL)-17A, the so-called IL-17 inhibitors, can effectively ease symptoms in people with ankylosing spondylitis (AS),…
Nearly one year of treatment with Cimzia (certolizumab pegol) led to sustained disease remission and a better quality of…
Simponi (golimumab) — a TNF inhibitor — is an effective therapy for people with ankylosing spondylitis (AS) and other chronic…
Lower blood levels of retinol-binding protein 4 (RBP4) — a protein associated with inflammation, among other processes — in…
People with ankylosing spondylitis (AS) are at a greater risk of developing certain inflammatory diseases — specifically, Behcet’s disease,…
Baduanjin qigong training, a traditional Chinese exercise, may reduce fatigue and morning stiffness in people with ankylosing spondylitis (AS), according…
Filgotinib, an investigational therapy for ankylosing spondylitis (AS) and other inflammatory diseases, was able to significantly reduce disease…